Monitoring primary breast cancer throughout chemotherapy using FDG-PET

Author： McDermott Garry   Welch Andrew   Staff Roger   Gilbert Fiona   Schweiger Lutz   Semple Scott   Smith Tim   Hutcheon Andrew   Miller Iain   Smith Ian   Heys Steven  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.102, Iss.1, 2007-03, pp. : 75-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDG-PET imaging predicts response to chemotherapy in lung cancer patients

By  

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 243-245

Future Medicine

Access to resources Recommend Favorite

A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases

By Isasi Carmen   Moadel Renee   Blaufox M.  

Breast Cancer Research and Treatment, Vol. 90, Iss. 2, 2005-03 ,pp. : 105-112

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging

By Martincich Laura  

Breast Cancer Research and Treatment, Vol. 83, Iss. 1, 2004-01 ,pp. : 67-76

Springer Publishing Company

Access to resources Recommend Favorite

The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature

By Peare Rebecca  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 281-290

Springer Publishing Company

Access to resources Recommend Favorite

Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases

By Hama Yukihiro  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 191-193

Springer Publishing Company

Access to resources Recommend Favorite